Thus, in this study, we aim to investigate the significance of VEGFR1- and VEGFR2-expressing non-tumor cells including BMDCs, which constitute important components of the tumor microenvironment, in esophageal cancer progression, and to determine whether targeting these cells could suppress tumor angiogenesis and progression. This evidence concerns the gene FLT1 and neoplasm.